Effects of Chitosan-Carboxymethyl Dextran Nanoparticles on Cell Proliferation and on Serum Cytokine Regulation
The bioactivity of chitosan-carboxymethyl dextran nanoparticles (CDNP) made using chitosans with different degrees of deacetylation (DA) (CDNP98: CDNP made with 98% DA chitosan; CDNP78: CDNP made with 78% DA chitosan) were tested by analysis of their in vitro effects on HeLa tumor cell and mouse fibroblast proliferation, and their in vivo effects on the regulation of mouse serum cytokine levels. CDNPs (50 to 100 g/ml) induced higher fibroblast proliferation than chitosans (CDNP98 > CDNP78 > chitosan), and were also more effective than chitosans in inhibition of HeLa cell proliferation in a dose-dependent manner (25 to 100 g/ml) (CDNP78 > CDNP98 > chitosans). CDNPs also induced a higher serum IL-5 level than chitosans (CDNP98 > CDNP78 > chitosans) within 3 h, and CDNP78 had a greater impact on IL-6 regulation but regulated IL-10 over a shorter duration than CDNP98 within the first 3 h. Combined with their ability to reduce serum IL-17 at 24 h, these biocompatible, immuno-active CDNPs demonstrated the potential to be applied as biomedical materials.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Publication date: June 1, 2010
More about this publication?
- Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites